Last updated October 22, 2026

Hemodynes

Developing blood-viscosity testing to personalise coronary CT assessments

Cardiovascular HealthMedical ImagingLab Instruments

Assessing coronary artery narrowing is difficult when blood-flow measurements sit near treatment thresholds. Blood viscosity varies between patients and affects CT-based blood-flow calculations, yet models using a constant value do not capture these individual differences.

Hemodynes is developing a blood viscometer and software that combine measured blood viscosity with coronary CT images. The system aims to help researchers compare standard and personalised assessments of coronary blood flow.

Investor Signals

What stands out about Hemodynes

Interested in More Startups Like Hemodynes?

Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.

Get Deal Flow

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.